Interestingly, OPN-/− mice showed significantly reduced tumor burden and significantly lower osteoclast numbers, when challenged with HFD, compared to wild-type controls (Figures 5A-5B), suggesting that osteopontin was a tumor- promoting and osteoclastogenic factor during HFD. Here, SPP1 is linked to neoplasm.